We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

CPS Technologies Q3 2026: Stock Issuance Lifts Total Assets

CPS Technologies Corp. filed its Form 10-Q for the fiscal quarter ended September 26, 2026, reporting third-quarter and nine-month financial results along with a significant common stock issuance completed during the period.

Shwetambri Chauhan | 10 November 2026

State Street Reports 6% Stake in Universal Corp/VA

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing a 6% beneficial ownership position in Universal Corp/VA as of September 30, 2026.

Shwetambri Chauhan | 10 November 2026

State Street Reports 5% Stake in Vanda Pharmaceuticals

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 3,010,531 shares of Vanda Pharmaceuticals Inc. common stock as of September 30, 2026.

Anjali Anand | 10 November 2026

State Street Discloses 14.4M Shares in USA Rare Earth

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 14,433,295 shares of common stock in USA Rare Earth Inc as of September 30, 2026.

Manish Choudhary | 10 November 2026

State Street Reports 4.6% Stake in Vera Therapeutics

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 3,301,893 shares of Vera Therapeutics Inc common stock as of September 30, 2026.

Nitish Kishor | 10 November 2026

Exagen Files S-3 Shelf for $150M, ATM Pact with TD Securities

Exagen Inc. filed a Form S-3 registration statement with the SEC on November 10, 2026, covering up to $150.0 million in securities and including a sales agreement prospectus supplement for up to $50.0 million in common stock through TD Securities (USA) LLC.

Manish Choudhary | 10 November 2026

State Street Reports 4.4% Stake in Verastem Inc

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 4,020,999 shares of Verastem Inc common stock as of September 30, 2026.

Anjali Anand | 10 November 2026

State Street Reports 4.6% Stake in Vir Biotechnology

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 7,822,781 shares of Vir Biotechnology Inc common stock as of September 30, 2026.

Shwetambri Chauhan | 10 November 2026

State Street Reports 6% Stake in Voyager Technologies

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing a 6% beneficial ownership position in Voyager Technologies Inc. common stock as of September 30, 2026.

Aakashdeep | 10 November 2026

State Street Reports 3.8% Stake in Wolfspeed

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,001,159 shares of Wolfspeed Inc common stock as of September 30, 2026.

Shwetambri Chauhan | 10 November 2026
Support

Hi! How can we help you today?

Loading…